The European Commission has responded to the Joint Committee of the European Supervisory Authorities’ concerns about the delayed adoption of draft RTS on risk mitigation techniques for non-centrally cleared OTC derivatives under EMIR. In its response, the Commission agrees that the delay in adopting the draft RTS should be kept as short as possible, but that the delay is caused by the need to complete legal reviews to ensure that the rules provide clarity and certainty.